scholarly journals Successful Treatment of a Metastatic Hormone-Producing Adrenal Cancer by a Combination of Mitotane, Tegafur and Surgical Resection.

1990 ◽  
Vol 37 (5) ◽  
pp. 753-762
Author(s):  
SETSUKO NAKAMURA ◽  
NOBUAKI KUZUYA ◽  
YOSHINOBU KOIDE ◽  
MASAKO MATSUMARA ◽  
YASUKO WATANABE ◽  
...  
2007 ◽  
Vol 10 (1) ◽  
pp. 58-62 ◽  
Author(s):  
Akihiro Nakajo ◽  
Shoji Natsugoe ◽  
Shuichi Hokita ◽  
Sumiya Ishigami ◽  
Hiroyuki Takatori ◽  
...  

Author(s):  
James Felker ◽  
Brianna Patterson ◽  
David Wrubel ◽  
Anna Janss

Abstract Prolactinomas are a rare subset of brain tumors in pediatrics. We report a child with a prolactin secreting macroadenoma which was refractory to initial treatment with a dopamine antagonist. Given the location of her tumor she was ineligible for surgical resection. Temozolomide (200 mg/m


Sarcoma ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Anne C. Onishi ◽  
Alexander M. Hincker ◽  
Francis Y. Lee

Chondrosarcoma, a primary malignancy of bone, has eluded successful treatment with modern chemotherapeutic and radiation regimens. To date, surgical resection of these tumors remains the only curative treatment offered to patients with this diagnosis. Understanding and exploring the nature of chemotherapy and radiation resistance in chondrosarcoma could lead to new molecular targets and more directed therapy for these notoriously difficult-to-treat tumors. Here we review the most current hypotheses regarding the molecular mechanisms mediating chemotherapy and radiation resistance and the future direction of chondrosarcoma therapy research.


2001 ◽  
Vol 46 (4) ◽  
pp. 225-226 ◽  
Author(s):  
Sang-Ahm Lee ◽  
Ji Yeon Ryu ◽  
Soon Keum Lee ◽  
Joong-Koo Kang

1995 ◽  
Vol 14 (5) ◽  
pp. 445-448 ◽  
Author(s):  
P. Seguin ◽  
B. Degeilh ◽  
I. Grulois ◽  
A. Gacouin ◽  
S. Maugendre ◽  
...  

2003 ◽  
Vol 25 (2) ◽  
pp. 153-158 ◽  
Author(s):  
Megan K. Dishop ◽  
Brad W. Warner ◽  
Louis P. Dehner ◽  
Vesna M. Kriss ◽  
Martha F. Greenwood ◽  
...  

Nephrology ◽  
2012 ◽  
Vol 18 (1) ◽  
pp. 74-75
Author(s):  
Lorraine PY Kwan ◽  
Cindy BY Choy ◽  
Tak Mao Chan ◽  
Wai Sing Suen ◽  
Desmond YH Yap

2005 ◽  
Vol 37 (9) ◽  
pp. 694-696 ◽  
Author(s):  
Kivanc Sadik Metin ◽  
Baran Sevket Ugurlu ◽  
Birol Kabakci ◽  
Nejat Osman Sariosmanoglu ◽  
Eyüp Hazan ◽  
...  

Author(s):  
Stephanie Schmitt ◽  
Erin Trovillion

To date, there have only been 46 patients reported in the literature with trisomy 18 and hepatoblastoma. We describe the case of an 11-month-old female with trisomy 18 and hepatoblastoma who was successfully treated by pairing surgical resection with a modified chemotherapy regimen omitting doxorubicin given her underlying cardiac abnormalities. Our case successfully demonstrates how chemotherapy regimens can be modified to accommodate for other underlying abnormalities and emphasizes that routine screening guidelines should exist for patients with trisomy 18 to allow for earlier detection and treatment.


Sign in / Sign up

Export Citation Format

Share Document